In NMDs, the age of onset, severity, and progression differ significantly even within the same disease, reflecting the influence of genetic modifiers (e.g., SMN2 copy number in SMA) and environmental factors [1,3]. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.